GRAIL, Inc.

SEC filing

Biotechnology · Menlo Park, CA

Form D on EDGAR

Amount raised$325Msold at filing

Total offering$325M

Investors in the raise17count reported to the SEC

FiledNov 7, 2025first sale Oct 21, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Aaron FreidinExecutive Officer

Sarah KrevansDirector

Gregory SummeDirector

Josh OfmanExecutive Officer

Steve MizellDirector

William ChaseDirector

Robert RagusaExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.